196 related articles for article (PubMed ID: 14673953)
1. Neutralizing VEGF bioactivity with a soluble chimeric VEGF-receptor protein flt(1-3)IgG inhibits testosterone-stimulated prostate growth in castrated mice.
Lissbrant IF; Hammarsten P; Lissbrant E; Ferrara N; Rudolfsson SH; Bergh A
Prostate; 2004 Jan; 58(1):57-65. PubMed ID: 14673953
[TBL] [Abstract][Full Text] [Related]
2. Testosterone induces vascular endothelial growth factor synthesis in the ventral prostate in castrated rats.
Häggström S; Lissbrant IF; Bergh A; Damber JE
J Urol; 1999 May; 161(5):1620-5. PubMed ID: 10210429
[TBL] [Abstract][Full Text] [Related]
3. Androgen withdrawal inhibits tumor growth and is associated with decrease in angiogenesis and VEGF expression in androgen-independent CWR22Rv1 human prostate cancer model.
Cheng L; Zhang S; Sweeney CJ; Kao C; Gardner TA; Eble JN
Anticancer Res; 2004; 24(4):2135-40. PubMed ID: 15330153
[TBL] [Abstract][Full Text] [Related]
4. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
Guo Y; Wang S; Hoot DR; Clinton SK
J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of prostate tumor growth and bone remodeling by the vascular targeting agent VEGF121/rGel.
Mohamedali KA; Poblenz AT; Sikes CR; Navone NM; Thorpe PE; Darnay BG; Rosenblum MG
Cancer Res; 2006 Nov; 66(22):10919-28. PubMed ID: 17108129
[TBL] [Abstract][Full Text] [Related]
6. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
7. Altered levels of angiopoietin 1 and tie 2 are associated with androgen-regulated vascular regression and growth in the ventral prostate in adult mice and rats.
Johansson A; Rudolfsson SH; Wikström P; Bergh A
Endocrinology; 2005 Aug; 146(8):3463-70. PubMed ID: 15845622
[TBL] [Abstract][Full Text] [Related]
8. Secretion of soluble VEGF receptor 2 by microvascular endothelial cells derived by human benign prostatic hyperplasia.
Stachon A; Aweimer A; Stachon T; Tannapfel A; Thoms S; Ubrig B; Köller M; Krieg M; Truss MC
Growth Factors; 2009 Apr; 27(2):71-8. PubMed ID: 19199116
[TBL] [Abstract][Full Text] [Related]
9. A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia.
Sela S; Itin A; Natanson-Yaron S; Greenfield C; Goldman-Wohl D; Yagel S; Keshet E
Circ Res; 2008 Jun; 102(12):1566-74. PubMed ID: 18515749
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury.
Hutter R; Carrick FE; Valdiviezo C; Wolinsky C; Rudge JS; Wiegand SJ; Fuster V; Badimon JJ; Sauter BV
Circulation; 2004 Oct; 110(16):2430-5. PubMed ID: 15477421
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
Ma X; Ottino P; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
[TBL] [Abstract][Full Text] [Related]
12. Adenoviral gene transfer with soluble vascular endothelial growth factor receptors impairs angiogenesis and perfusion in a murine model of hindlimb ischemia.
Jacobi J; Tam BY; Wu G; Hoffman J; Cooke JP; Kuo CJ
Circulation; 2004 Oct; 110(16):2424-9. PubMed ID: 15477417
[TBL] [Abstract][Full Text] [Related]
13. Essential role of vascular endothelial growth factor and Flt-1 signals in neointimal formation after periadventitial injury.
Zhao Q; Egashira K; Hiasa K; Ishibashi M; Inoue S; Ohtani K; Tan C; Shibuya M; Takeshita A; Sunagawa K
Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2284-9. PubMed ID: 15472126
[TBL] [Abstract][Full Text] [Related]
14. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
[TBL] [Abstract][Full Text] [Related]
15. Hepatic microcirculation and cholangiocyte physiopathology.
Gaudio E; Onori P; Franchitto A; Pannarale L; Alpini G; Alvaro D
Ital J Anat Embryol; 2005; 110(2 Suppl 1):71-5. PubMed ID: 16101023
[TBL] [Abstract][Full Text] [Related]
16. Angiogenic activity of swine granulosa cells: effects of hypoxia and vascular endothelial growth factor Trap R1R2, a VEGF blocker.
Bianco F; Basini G; Grasselli F
Domest Anim Endocrinol; 2005 Apr; 28(3):308-19. PubMed ID: 15760671
[TBL] [Abstract][Full Text] [Related]
17. Modulating testosterone stimulated prostate growth by phenethyl isothiocyanate via Sp1 and androgen receptor down-regulation.
Beklemisheva AA; Feng J; Yeh YA; Wang LG; Chiao JW
Prostate; 2007 Jun; 67(8):863-70. PubMed ID: 17431886
[TBL] [Abstract][Full Text] [Related]
18. Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats.
Franck-Lissbrant I; Häggström S; Damber JE; Bergh A
Endocrinology; 1998 Feb; 139(2):451-6. PubMed ID: 9449610
[TBL] [Abstract][Full Text] [Related]
19. Effects of finasteride on vascular endothelial growth factor.
Häggström S; Tørring N; Møller K; Jensen E; Lund L; Nielsen JE; Bergh A; Damber JE
Scand J Urol Nephrol; 2002; 36(3):182-7. PubMed ID: 12201932
[TBL] [Abstract][Full Text] [Related]
20. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
